Profile: Akorn Inc (AKRX.O)
Akorn Inc. (Akorn), incorporated on January 20, 1971, together with its subsidiaries, is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments: Prescription Pharmaceuticals and the Consumer Health. The Company is engaged in the development, manufacturing and marketing of generic pharmaceutical products in alternative dosage forms. It is focused on sterile and non-sterile dosage forms including, ophthalmics, injectables, oral liquids, otics, topicals, inhalants and nasal sprays. The Company's Akorn Consumer Health division (ACH) markets a portfolio of OTC brands and various formulations of private-label OTC pharmaceutical products. Its OTC brand is TheraTears Therapy for Your Eyes, which is a family of therapeutic eye care products, including dry eye therapy lubricating eye drops, eyelid and eyelash cleansing foam and eye nutrition supplements.
The Company also markets various specialty OTC products, including Zostrix, Sinus Buster, MagOx, Maginex, Multi-betic, Diabetic Tussin and Dia-Derm. It also markets a portfolio of branded and generic companion animal prescription pharmaceutical products under the Akorn Animal Health label. Its animal health products include Anased and VetaKet, veterinary sedatives; Tolazine and Yobine, sedative reversing agents, and Butorphic, a pain reliever. The Company operates pharmaceutical manufacturing facilities in Decatur, Illinois; Somerset, New Jersey; Amityville, New York; Hettlingen, Switzerland, and Paonta Sahib, Himachal Pradesh, India. It also operates a central distribution warehouse in Gurnee, Illinois and additional distribution facilities in Amityville, New York and Decatur, Illinois. The Company's research and development (R&D) centers are located in Vernon Hills, Illinois; Copiague, New York, and Cranbury, New Jersey.
The Prescription Pharmaceuticals segment consists of generic and branded prescription pharmaceuticals in a range of dosage forms, including sterile ophthalmics, injectables and inhalants and non-sterile oral liquids, topicals and nasal sprays and otics. It also markets a range of pain management drugs, including drugs subject to the Controlled Substances Act. It markets a range of branded ophthalmic and respiratory products, including brands, such as Akten, a topical ocular anesthetic gel; AzaSite, an antibiotic used to treat bacterial conjunctivitis; Cosopt, Cosopt PF, Betimol and Zioptan, which are used in the treatment of glaucoma, and Xopenex Inhalation Solution, which is used in the treatment or prevention of bronchospasm. The Prescription Pharmaceuticals segment's products include Atropine Sulfate Ophthalmic Solution, Clobetasol Propionate Ointment, Clobetasol Propionate Cream, Ephedrine Sulfate Injection, Lidocaine Ointment, Methylene Blue Injection, Myorisan Soft Gelatin Capsules, Nembutal Sodium Solution, Phenylephrine Hydrochloride Ophthalmic Solution and Zioptan.
The Consumer Health segment consists of branded and private-label OTC products and animal health products dispensed by veterinary professionals. Its branded and private-label OTC products are focused on ophthalmics, including a dry eye treatment TheraTears Therapy for Your Eyes. It also markets other OTC consumer health products, including Mag-Ox, a magnesium supplement and the Diabetic Tussin line of cough and cold products. Its animal health portfolio is focused on products complementary to its human health prescription portfolio. Its products within animal health portfolio include Anased and VetaKet veterinary sedatives; Tolazine and Yobine, sedative reversing agents, and Butorphic, a pain reliever.
The Company competes with Teva Pharmaceutical Ltd., Apotex Inc., Fresenius Kabi AG, Hikma Pharmaceuticals plc, Novartis International AG, Perrigo Company plc, Pfizer Inc., Mylan N.V., Taro Pharmaceutical Industries Ltd. and Valeant Pharmaceuticals International, Inc., Allergan plc and Johnson & Johnson.
1925 W Field Ct Ste 300
LAKE FOREST IL 60045-4862
Company Web Links
- Akorn gets FDA warning letter for another manufacturing plant
- UPDATE 3-Akorn gets FDA warning letter for another manufacturing plant
- Akorn gets FDA's warning letter related to New Jersey manufacturing plant
- FDA flags concerns at Akorn's Amityville plant, shares slip
- UPDATE 2-FDA flags concerns at Akorn's Amityville plant, shares slip